These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4089523)

  • 21. The theophylline disposition after caffeine administration in liver cirrhosis: an index of liver function.
    Hartleb M; Romańczyk T; Becker A; Mańczyk I; Waluga M; Spalińska M; Zieliński M
    Ital J Gastroenterol; 1992; 24(6):332-7. PubMed ID: 1515659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between aminopyrine breath test and severity of liver disease in cirrhosis.
    Morelli A; Narducci F; Pelli MA; Farroni F; Vedovelli A
    Am J Gastroenterol; 1981 Aug; 76(2):110-3. PubMed ID: 6795921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of smoking on caffeine elimination in healthy volunteers and in patients with alcoholic liver cirrhosis.
    Joeres R; Klinker H; Heusler H; Epping J; Zilly W; Richter E
    Hepatology; 1988; 8(3):575-9. PubMed ID: 3371873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans.
    Mion F; Queneau PE; Rousseau M; Brazier JL; Paliard P; Minaire Y
    Hepatogastroenterology; 1995; 42(6):931-8. PubMed ID: 8847048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caffeine clearance by two point analysis: a measure of liver function in chronic liver disease.
    Wittayalertpanya S; Israsena S; Thamaree S; Tongnopnoua P; Komolmit P
    Tokai J Exp Clin Med; 1996 Dec; 21(4-6):195-201. PubMed ID: 9300980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of exogenous factors on the behavior of aminophenazone breath test in chronic liver diseases].
    Treutler J; Sensing H; Haustein KO; Hüller G
    Gastroenterol J; 1991; 51(3-4):132-5. PubMed ID: 1811657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 30-minute aminopyrine breath test: optimization of sampling times after intravenous administration of 14C-aminopyrine.
    Miotti T; Bircher J; Preisig R
    Digestion; 1988; 39(4):241-50. PubMed ID: 3220177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The diagnostic relevance of the aminopyrine breath test in liver disease].
    Wildgrube HJ; Stang H
    Z Gastroenterol; 1982 Nov; 20(11):667-72. PubMed ID: 7180067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma levels of atrial natriuretic peptide in patients with chronic liver disease.
    Kawasaki H; Uemasu J; Maeda N; Hirayama C; Kobayashi T; Sakurai H
    Am J Gastroenterol; 1987 Aug; 82(8):727-31. PubMed ID: 3037881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aminopyrine demethylation measured by breath analysis in cirrhosis.
    Bircher J; Küpfer A; Gikalov I; Preisig R
    Clin Pharmacol Ther; 1976 Oct; 20(4):484-92. PubMed ID: 975720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of prealbumin plasma levels as liver test.
    Rondana M; Milani L; Merkel C; Caregaro L; Gatta A
    Digestion; 1987; 37(2):72-8. PubMed ID: 3622940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnositic value of serum bile acid estimations in liver disease.
    Barnes S; Gallo GA; Trash DB; Morris JS
    J Clin Pathol; 1975 Jun; 28(6):506-9. PubMed ID: 1141454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Foreign substances as indicators of liver function].
    Preisig R
    Schweiz Med Wochenschr Suppl; 1985; 19():36-42. PubMed ID: 3864235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caffeine clearance test: a quantitative liver function assessment in patients with liver cirrhosis.
    Shyu JK; Wang YJ; Lee SD; Lu RH; Lo KJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 May; 57(5):329-34. PubMed ID: 8768380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and determinants of elevated plasma norepinephrine concentration in compensated cirrhosis.
    Rector WG; Robertson AD
    Am J Gastroenterol; 1994 Nov; 89(11):2049-53. PubMed ID: 7942734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of quantitative liver function tests to clinical, laboratory chemical and biopsy findings in patients with liver diseases].
    Albers I; Hartmann H; Creutzfeldt W
    Z Gastroenterol; 1988 Feb; 26(2):130-6. PubMed ID: 2577930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized controlled trial in humans.
    Verhoef P; Pasman WJ; Van Vliet T; Urgert R; Katan MB
    Am J Clin Nutr; 2002 Dec; 76(6):1244-8. PubMed ID: 12450889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass].
    Bolognesi M; Merkel C; Angeli P; Caregaro L; Gatta A
    Minerva Med; 1988 Dec; 79(12):1035-41. PubMed ID: 3211355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.